23rd Pharmaceutical & Medical Device Ethics and Compliance Congress Agenda Now Available; Early Bird Ends Friday 8/26
  • A Hybrid Onsite Conference and Internet Event
  • Sponsored by Pharmaceutical Compliance Forum
  • Media Partners: Policy & Medicine Compliance Update
  • October 24-26, 2022
  • Capitol Hyatt, Washington, DC
  • www.PharmaCongress.com

Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com

Click Here for discounted registration.

Click Here for Agenda.

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD

Mary A. Inman, JD
Whistleblower Counsel; Partner, Constantine, San Francisco, CA and London, UK

Kelly Begg Lawrence, JD
Assistant US Attorney & Chief, Health Care Fraud, District of Massachusetts, US Department of Justice, Boston, MA

Glenn Leon, JD
Incoming Fraud Section Chief, Criminal Division, US Department of Justice; Former SVP & Chief Ethics & Compliance Officer, Hewlett Packard, Washington, DC

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC

Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC

  • We are thrilled to welcome you back to Washington DC for the in-person/hybrid PCF Congress!
  • Join us live to take advantage of numerous interpersonal networking opportunities with colleagues and educational opportunities at our robust exhibit hall with our industry partners
  • An invitation-only, closed-door Chief Compliance Officer (CCO) Roundtable on the morning of Tuesday, October 25 For more information contact pcf.org.info@gmail.com.
  • Annual reports and updates provided by DOJ, FDA, and OIG
  • Over 30 current topics addressing crucial ethics, compliance and legal issues
  • An industry-only, closed-door session for pharma and device ethics, compliance and legal professionals on Wednesday, October 26

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 23, 2022: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce that the Twenty-Third Pharmaceutical & Medical Device Ethics and Compliance Congress is returning to the Hyatt Regency on Capitol Hill in Washington, DC on October 24-26, 2022.


Khelin N. Aiken, JD Partner, North America FDA Practice, Baker McKenzie; Former Regulatory Counsel, FDA

Meredith S. Auten, JD Partner, Morgan, Lewis & Bockius LLP

Kristiana Bankova, MS Senior Manager Forensics, EY

Samantha Barrett Badlam, JD Counsel, Ropes & Gray

Eric M. Baim, MA, JD Partner, Dovetail Consulting Group LLC; Former VP Compliance US, Shire

Rachel Batykefer Senior Director, Integrity & Compliance CIA Operations, Mallinckrodt

Ann E. Beasley, JD Chief Compliance Officer, Zai Lab

Allison Benkert, MBA Director Global Compliance Investigations, Seagen

Joshua Blank, JD Senior Attorney, Arnold & Porter

Jennifer Bragg, JD Partner, Skadden Arps LLP

Adam L. Braverman, JD Partner, Morrison & Foerster, Former US Attorney, Southern District of California

Terra Buckley, JD Vice President, Head of Compliance Advisory Services, MedPro Systems; Vice President Compliance, Mesoblast

Tim Canonico Principal, Pharmaceutical & Life Sciences, Risk & Regulatory Leader, PwC

Susy Cardoso, JD, LLM Former Executive Director of Ethics & Compliance, Amarin

Craig Carpenito, JD Partner, King & Spalding; Former US Attorney, New Jersey

Cynthia Cetani, LPEC Chief Integrity & Compliance Officer, Indivior

Cheryl Chamallas Sr. Director, Global Compliance Risk, argenx

Masha Chestukhin, MSJ Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme

Steven Cohen, MBA Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly

Clarissa Crain Managing Director, Deloitte & Touche LLP

Tiffany Cummings-Damiani, MBA Head of Global Compliance, JD, Insmed Incorporated

Mahnu V. Davar, MA, JD Partner, Arnold & Porter

Jake DeBoever, JD Vice President, Chief Compliance Officer, Dermavant Sciences

Gildas Durand Partner/Principal, Forensic & Integrity Services, EY

David Falcone Associate Vice President Global Compliance, Merz Aesthetics

J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US Managing Director, Epsilon Life Sciences LLC

Nicole L. Felician, JD Executive Director, Legal Regulatory, Digital Health, Patient Centricity, Cell Therapies, Astellas Pharma US

Kellie Fidler, PMP Senior Director, Compliance Risk Assessment, Monitoring and Operations, Bristol-Myers Squibb

Bethany Fox, JD Vice President, Commercial Legal Affairs, Exelixis

Sara Frank, JD Principal, Choate, Hall & Stewart LLP

Cari A. Gallman, JD Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb

Nereyda Garcia, JD Head, Ethics & Compliance, US Business Unit, Takeda

Gary F. Giampetruzzi, JD Partner, Paul Hastings

Edward P. Glynn, MBA Principal, EY

Gejaa T. Gobena, JD Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ

Tom Gregory Partner, Forensic & Integrity Services, EY

Noor Haq, CCEP, MS, MBA, CIA Executive Director, US Compliance, Amgen

Beth Hardcastle, JD Partner, Sidley Austin LLP

Saul B. Helman MD, MBA President, Epsilon Life Sciences

Michael Hercz, JD Senior Vice President & General Counsel, Sentynl

Emily F. Hodge, JD Partner, Choate, Hall & Stewart LLP

Todd Haugh, JD Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University

Denis Jacob Managing Director, Risk & Regulatory, PwC

Brenna E. Jenny, JD Partner, Sidley

Jeffrey Kawalek, MBA Deputy, Chief Compliance Officer, Jazz Pharmaceuticals

Andrea Kocharyan, JD Vice President, Head of Legal and Compliance, Zealand Pharma

Daniel Koerner Senior Director, Potomac River Partners

JJ Kuhn, JD Vice President, Chief Counsel, Global Investigations, Medtronic

Stephanie Kurteff, JD, HCCP Head of Compliance, Healthcare Compliance Officer, Medicines360

Rebekah Latchis, JD Senior Director, Americas Office of Ethics and Compliance, Medtronic

Kirsten Liston Principal and Founder, Rethink Compliance

Michael K. Loucks, JD Partner, Skadden Arps LLP; Former Acting US Attorney, Massachusetts, DOJ

Seth H. Lundy, JD Partner, FDA and Life Sciences, King & Spalding

Kevin J. Ma, JD US Head of Compliance & Managing Counsel, PharmaEssentia USA

Jim Massey, MS
Chief Sustainability Officer, Zai Lab

Chris C. Matteson
US Forensics Compliance Services Executive, Forensic & Integrity Services, EY

Kirstin Mayer, JD
Head of US Compliance, Argenx

Dana S. McMahon, JD
Vice President, Global Chief Compliance Officer, Stryker

Rore Middleton, JD
Vice President, Compliance and Ethics at Blueprint Medicines, Member of Chief

Gregory F. Noonan, JD
Partner, Hogan Lovells; Former AUSA, Massachusetts & Southern District of California

Katherine Norris, MPA
Managing Director, Epsilon Life Sciences

Kristen Oberg, JD
Senior Vice President, Legal & Compliance, Mycovia Pharmaceuticals

John Patrick Oroho, JD
Executive Vice President, Chief Strategy Officer, Porzio Life Sciences; Principal, Porzio, Bromberg & Newman PC

Chelsea Ott, JD
Director, Global Regulatory, MedPro Systems

Danielle Pelot, JD
Partner, Choate, Hall & Stewart LLP

Joseph Philipose, JD
SVP, Chief Ethics & Compliance Officer, Emergent Biosolutions

Zoe Philippides, JD
Senior Vice President, Chief Ethics, Compliance & Privacy Officer, Moderna

Susan Pietras
Global Project Lead - Training, Communication and Policies, Sanofi

Lawrence P. Platkin, JD
Vice President and Head, U.S. Office of Compliance, Bayer US

Cory Potomis, MS
Director, Ethics & Compliance Strategy & Operations, Novo Nordisk, Plainsboro, NJ

Nikki Reeves, JD
Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding

Jennifer A. Romanski, JD
Senior Vice President, Porzio Life Sciences, LLC; Principal, Porzio, Bromberg & Newman PC

Howard Root, JD
Chairman, Reprise Biomedical; Former, CEO & Co-Founder, Vascular Solutions

Jeff Rosenbaum, MBA
Partner & Co-Founder, Dovetail Consulting Group

Monica Schroeter, CPA, CISA
Senior Director, Compliance & Privacy , SK Life Science

Michael L. Shaw, JD
Principal, Global Head of Risk & Compliance, ZS

Tara Shewchuk, JD, LLM
Chief Ethics & Compliance Officer, Medtronic

Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory

Ed Sleeper, MS
Ethics & Compliance Officer (U.S. & Europe), HUTCHMED

Tim Slone, MS, HCCP
Vice President, Global Compliance, Novavax

Kaarthick Subramanian, MBA
Vice President, Security and Privacy, ComplyScore; Vice President, Atlas Systems

Jack Tanselle, MBA
Managing Director, Deloitte & Touche LLP

Kelly J. Tope, JD, MBA
Head of USBU Ethics & Compliance Monitoring and Reporting Operations, Takeda

Annalisa Torrente-Haney, MS
Associate Director, Contract to Pay Operations US Business Partner, AstraZeneca

Manny Tzavlakis
Managing Partner, Helio Health Group; Chief Executive Officer, Helio Argos

Beth P. Weinman, JD
Counsel, Ropes & Gray; Former Associate Chief Counsel, FDA

Caroline West, JD
Board Member, Helio Argos

Justin Will, JD
Global Commercial Compliance Consulting & Managed Services Practice Leader, IQVIA

Ronald L. Wisor, Jr, JD
Partner, Hogan Lovells

Click Here for discounted registration.

Click Here for Agenda.


The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 100+ distinguished researched-based pharmaceutical manufacturers and biotech companies.


Joe Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics
(PCF Chair)

Christie Camelio
Chief Compliance and Risk Officer, EQRx

Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte

Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim

Margaret Sparks, JD
Head of Compliance, Vaccines & North America Ethics and Business Integrity, Sanofi

Donna White, CCEP
Vice President, Compliance, Chiesi


Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc.

Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic

Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker





The Congress is pending approval for Compliance Certification Board (CCB)® Continuing Education Units.

The Congress is pending approval for Pennsylvania CLE Credits.

Attendees can click here to request a Certificate of Attendance on which they can certify the number of hours they watched and can file with appropriate entities for credit.

The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those who have lost their jobs as a result of the COVID-19 pandemic.

Click here for more information.
For Congress registration information, visit https://www.pharmacongress.com/registration-splash/, email reginfo@hcconferences.com, or call 800-503-7419.

For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.

For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.